Clinical Trial Update: Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density [Phase 2]

View source ↗

Summary

Phase 2 study results for a Vitamin D compound (DP001) in postmenopausal women with low bone mineral density show safety and efficacy in treating osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• DP001

Snippet

Sponsor: Deltanoid Pharmaceuticals | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2010-01-11